87
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Comparison of a Fixed Combination of Domperidone and Paracetamol (Domperamol®) with Sumatriptan 50mg in Moderate to Severe Migraine: A Randomised UK Primary Care Study

, &
Pages 190-197 | Published online: 05 Aug 2008

References

  • Data on file, Servier Laboratories.
  • MacGregor, E. A., Wilkinson, M. and Bancroft, K. (1993). Domperidone plus paracetamol in the treatment of migraine. Cephalalgia, 13, 124–127.
  • International Headache Society Committee on Clinical Trials in Migraine (1991). Guidelines for controlled trials of drugs in migraine. First edition. Cephalalgia, 11, 1–12.
  • Pfaffenrath, V., Cunin, G., Sjonell, G. and Prendergast, S. L. (1998). Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache, 38, 184–190.
  • Longmore, J., Dowson, A. and Hill, R. G. (1999). Advances in migraine therapy —5HT receptor subtype-specific agonist drugs. Cum Opin. CPNS Invest. Drugs, 1(1), 39–53.
  • Waelkens, J. (1982). Domperidone in the prevention of complete classical migraine. BMJ, 284, 944.
  • Waelkens, J. (1984). Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia, 4, 85–90.
  • M/MS (2000). Haymarket Publishing Services Limited, London, August.
  • Migraine Management Guidelines. A strategy for managing migraine. Migraine in Primary Care Advisors (1997). Synergy Medical Education, London.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.